Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Strangfeld

Showing results (81-90 of 131) with videos related to

Pageof 14
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 16, 2023
Charakterisierung von Patienten mit Psoriasisarthritis in der dermatologischen und rheumatologischen Versorgung: Analyse von zwei Registern: Characterization of patients with psoriatic arthritis in dermatologic and rheumatologic care: analysis of two registriesMatthias Augustin, Lisa Lindner, Laura Kühl, et al.
RMD Open|September 4, 2020
National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRDRebecca Hasseli, Ulf Mueller-Ladner, Tim Schmeiser, et al.
RMD Open|January 22, 2021
Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseasesRebecca Hasseli, Ulf Mueller-Ladner, Bimba F Hoyer, et al.
RMD Open|October 21, 2021
TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMDAnne Constanze Regierer, Rebecca Hasseli, Martin Schäfer, et al.
Zeitschrift Fur Rheumatologie|April 3, 2024
[Current data on rheumatological care: annual report from the National database (NDB) of the regional collaborative arthritis centres in Germany]Katinka Albrecht, Katja Thiele, Tobias Alexander, et al.
The Lancet. Rheumatology|April 21, 2020
Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registriesMilena A Gianfrancesco, Kimme L Hyrich, Laure Gossec, et al.
Zeitschrift Fur Rheumatologie|May 5, 2025
[Annual report 2025 from the National Database of the Regional Collaborative Rheumatology Centers in Germany]Katinka Albrecht, Katja Thiele, Tobias Alexander, et al.
Annals of the Rheumatic Diseases|June 17, 2016
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registersLouise K Mercer, Johan Askling, Pauline Raaschou, et al.
Pharmacoepidemiology and Drug Safety|August 14, 2024
Rhekiss-The German Register for Child Wish and Pregnancies in Inflammatory Rheumatic DiseasesAnja Strangfeld, Yvette Meissner, Anja Weiß, et al.
Aging Clinical and Experimental Research|February 22, 2025
Musculoskeletal diseases, infections and vaccines: state of the art, research perspectives and educational needsFiona Ecarnot, Jotheeswaran Amuthavalli Thiyagarajan, Mario Barbagallo, et al.
Pageof 14

Showing results (81-90 of 131) with videos related to

Sort By:
Pageof 14
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 16, 2023
Charakterisierung von Patienten mit Psoriasisarthritis in der dermatologischen und rheumatologischen Versorgung: Analyse von zwei Registern: Characterization of patients with psoriatic arthritis in dermatologic and rheumatologic care: analysis of two registriesMatthias Augustin, Lisa Lindner, Laura Kühl, et al.
RMD Open|September 4, 2020
National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRDRebecca Hasseli, Ulf Mueller-Ladner, Tim Schmeiser, et al.
RMD Open|January 22, 2021
Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseasesRebecca Hasseli, Ulf Mueller-Ladner, Bimba F Hoyer, et al.
RMD Open|October 21, 2021
TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMDAnne Constanze Regierer, Rebecca Hasseli, Martin Schäfer, et al.
Zeitschrift Fur Rheumatologie|April 3, 2024
[Current data on rheumatological care: annual report from the National database (NDB) of the regional collaborative arthritis centres in Germany]Katinka Albrecht, Katja Thiele, Tobias Alexander, et al.
The Lancet. Rheumatology|April 21, 2020
Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registriesMilena A Gianfrancesco, Kimme L Hyrich, Laure Gossec, et al.
Zeitschrift Fur Rheumatologie|May 5, 2025
[Annual report 2025 from the National Database of the Regional Collaborative Rheumatology Centers in Germany]Katinka Albrecht, Katja Thiele, Tobias Alexander, et al.
Annals of the Rheumatic Diseases|June 17, 2016
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registersLouise K Mercer, Johan Askling, Pauline Raaschou, et al.
Pharmacoepidemiology and Drug Safety|August 14, 2024
Rhekiss-The German Register for Child Wish and Pregnancies in Inflammatory Rheumatic DiseasesAnja Strangfeld, Yvette Meissner, Anja Weiß, et al.
Aging Clinical and Experimental Research|February 22, 2025
Musculoskeletal diseases, infections and vaccines: state of the art, research perspectives and educational needsFiona Ecarnot, Jotheeswaran Amuthavalli Thiyagarajan, Mario Barbagallo, et al.
Pageof 14